Abbott expands nutrition portfolio for Rare Metabolic Disorders in India supriya kashyap kashyap18 Aug 2017 10:00 AM ISTMumbai : Abbott, a leader in nutrition science research and development, has announced increased access to Abbott’s nutrition metabolic formulas...
Granules India revenue increases by 10 percent to Rs 386 Crore Ruby Khatun Khatun18 Aug 2017 9:45 AM ISTHYDERABAD: Granules India Ltd., a growing pharmaceutical manufacturing company, announced financial results for its first quarter ended 30th June,...
Knee Surgery Implants now under Price Ceiling, Effective Immediately supriya kashyap kashyap18 Aug 2017 9:33 AM ISTNew Delhi : Just a day after the Prime Minister, in his independence day address was seen promising that he will bring down the price of knee...
USFDA issues EIR for Granules Indias Gagillapur plant Ruby Khatun Khatun17 Aug 2017 12:09 PM ISTNew Delhi: Drug firm Granules India on Wednesday said the US health regulator has issued establishment inspection report for its Gagillapur plant in...
Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments supriya kashyap kashyap17 Aug 2017 12:09 PM ISTNew Delhi : Johnson & Johnson Private Limited today announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the...
Biocon pulls application for EU approval of two drugs Ruby Khatun Khatun17 Aug 2017 12:01 PM ISTBiocon Ltd has withdrawn its application seeking European Union approval for two drugs after the EU drugs regulator sought re-inspection of their...
Cipla shares surge over 6 percent after Q1 earnings Ruby Khatun Khatun17 Aug 2017 11:59 AM ISTNew Delhi: Shares of drug major Cipla rose over 6 per cent after the company reported 23.63 per cent rise in consolidated net profit for the first...
Zydus Cadila gets USFDA nod for blood pressure drug Ruby Khatun Khatun17 Aug 2017 11:58 AM ISTNew Delhi: Cadila Healthcare on Wednesday said its group firm Zydus Cadila has received final approval from the US health regulator to market blood...
Zydus settles patent case over Aptalis drug Canasa Ruby Khatun Khatun16 Aug 2017 11:00 AM ISTNew Delhi: Zydus group firm Cadila Healthcare on Monday said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative...
Far-right clashes: Merck CEO quits Trump panel Ruby Khatun Khatun16 Aug 2017 10:00 AM ISTCHARLOTTESVILLE: US President Donald Trump faced renewed pressure on Monday to respond more forcefully to a violent white-nationalist rally in...
Chinas Fosun, Shanghai Pharma say bid for stake in US drugmaker Arbor Ruby Khatun Khatun16 Aug 2017 9:30 AM ISTHONG KONG: A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co are among bidders for a stake in U.S. speciality drugmaker Arbor...
Natco Pharma gets USFDA nod to market renal disease drug Ruby Khatun Khatun16 Aug 2017 9:00 AM ISTNew Delhi: Natco Pharma on Monday said it has received approval from the US health regulator to market Lanthanum Carbonate chewable tablets used in...
